scispace - formally typeset
Patent

Multilayer genetic safety kill circuits based on single cas9 protein and multiple engineered grna in mammalian cells

TLDR
In this article, the authors describe a regulatory system composed of a CRISPR-associated nuclease and at least two distinct guide RNAs (gRNAs), which modulates cleavage and transcription, including repression and activation, in a mammalian cell such as a human cell.
Abstract
Aspects of the disclosure relate to synthetic regulatory systems composed of a multifunctional Cas [clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas)] nuclease and at least two distinct guide RNAs (gRNAs). The synthetic regulatory system modulates cleavage and transcription, including repression and activation, in a mammalian cell such as a human cell.

read more

Citations
More filters
Patent

Adenosine nucleobase editors and uses thereof

TL;DR: In this article, the authors provide fusion proteins comprising a Cas9 (e.g., a Cas 9 nickase) domain and adenosine deaminases that deaminate adenosines in DNA, and in some embodiments, the fusion proteins further comprise a nuclear localization sequence (NLS), and/or an inhibitor of base repair, such as, a nuclease dead inosine specific nucolate (dISN).
Patent

Cas9 proteins including ligand-dependent inteins

TL;DR: In this article, the authors provide compositions, methods, systems, and kits for controlling the activity of RNA-programmable endonucleases, such as Cas9, or for controlling proteins comprising a Cas9 variant fused to a functional effector domain.
Patent

Delivery of negatively charged proteins using cationic lipids

TL;DR: In this article, the authors present compositions, methods, strategies, kits, and systems for the delivery of negatively charged proteins, protein complexes, and fusion proteins using cationic polymers or lipids.
Patent

Editing of CCR5 receptor gene to protect against HIV infection

TL;DR: In this paper, the authors present systems, compositions, and methods of introducing protective and/or loss-of-function variants of CCR5 and CCR2 for HIV infection and progression.
References
More filters
Journal ArticleDOI

A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

TL;DR: This study reveals a family of endonucleases that use dual-RNAs for site-specific DNA cleavage and highlights the potential to exploit the system for RNA-programmable genome editing.
Journal ArticleDOI

Highly efficient Cas9-mediated transcriptional programming

TL;DR: An improved transcriptional regulator obtained through the rational design of a tripartite activator, VP64-p65-Rta (VPR), fused to nuclease-null Cas9 is described and demonstrated in activating endogenous coding and noncoding genes and stimulating neuronal differentiation of human induced pluripotent stem cells (iPSCs).
PatentDOI

Orthogonal cas9 proteins for rna-guided gene regulation and editing

TL;DR: In this article, the use of multiple orthogonal Cas9 proteins to simultaneously regulate corresponding genes or simultaneously and independently edit corresponding genes is described. But the authors do not consider the effect of the Cas9 protein on the expression of the target nucleic acid.
Journal ArticleDOI

Multiplex genome engineering in human cells using all-in-one CRISPR/Cas9 vector system

TL;DR: This work established a system for constructing all-in-one expression vectors containing multiple guide RNA expression cassettes and a Cas9 nuclease/nickase expression cassette that provides an efficient targeting strategy for multiplex genome/epigenome editing, simultaneous activation/repression of multiple genes, and beyond.
Related Papers (5)